VEXAS syndrome: An update.
Khitri MY, Hadjadj J, Mekinian A, Jachiet V.
Joint Bone Spine. 2024 Jul;91(4):105700. doi: 10.1016/j.jbspin.2024.105700. Epub 2024 Feb 1.
[VEXAS Syndrome].
Jachiet V, Comont T, Kosmider O, Zhao LP, Mekinian A, Fain O, Hadjadj J.
Rev Prat. 2025 Feb;75(2):196-200.
Germline and somatic genetic landscape of pediatric myelodysplastic syndromes.
Kotmayer L, Kennedy AL, Wlodarski MW.
Haematologica. 2025 Sep 1;110(9):1974-1986. doi: 10.3324/haematol.2024.285700. Epub 2025 Jun 26.
Diagnostic difficulties in pernicious anemia.
Oo TH.
Discov Med. 2019 Nov-Dec;28(155):247-253.
Schimke Immunoosseous Dysplasia.
Lippner E, Lücke T, Salgado C, Boerkoel C, Lewis DB.
2002 Oct 1 [updated 2023 Mar 30]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
Bupropion-induced pancytopenia.
Kim JL, Chercover D, Masoudi H, Foltz L.
BMJ Case Rep. 2024 Nov 26;17(11):e262831. doi: 10.1136/bcr-2024-262831.
Juvenile myelomonocytic leukemia.
Proytcheva M.
Semin Diagn Pathol. 2011 Nov;28(4):298-303. doi: 10.1053/j.semdp.2011.08.007.
Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF, Velloso EDRP, Garanito MP, Leal AM, Siqueira SAC, Azevedo Neto RS, Rocha V, Zerbini MCN.
Ann Diagn Pathol. 2020 Apr;45:151459. doi: 10.1016/j.anndiagpath.2019.151459. Epub 2019 Dec 30.
Congenital dyserythropoietic anemias.
Wickramasinghe SN.
Curr Opin Hematol. 2000 Mar;7(2):71-8. doi: 10.1097/00062752-200003000-00001.
Anemia as the Main Manifestation of Myelodysplastic Syndromes.
Santini V.
Semin Hematol. 2015 Oct;52(4):348-56. doi: 10.1053/j.seminhematol.2015.06.002. Epub 2015 Jun 30.
